52 results
Page 2 of 3
8-K
EX-99.1
ceo zfujhhkzy5c5tov
13 Nov 19
Other Events
7:16am
8-K
EX-99.1
joq6fr 0qv
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
rhodpz2qt ed
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
viwgr
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
5kz39dij
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
u7ywwg
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
4cg 3s9gxy
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-10.1
89y9ybfp
4 Mar 19
Entry into a Material Definitive Agreement
7:05am
8-K
EX-99.1
4w8ue 9s5vruvy
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-10.1
h0r81hwcoqp97
4 Jan 19
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-99.1
15dcu
10 Dec 18
Other Events
2:07pm
8-K
EX-99.1
hggzdclg7depg
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
u128wqhf98iu1
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am
8-K
EX-99.1
u5v5gj0r98qnuny uv
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
EX-99.1
5hgn oa8v5zqny5
7 Aug 18
Recro Pharma Reports Second Quarter 2018 Financial Results
7:05am
8-K
EX-99.1
bbokj
9 May 18
Recro Pharma Reports First Quarter 2018 Financial Results
7:01am
8-K
EX-99.1
ce2ppk bcx6dk3yg0w
7 May 18
Other Events
9:41am
8-K
EX-99.1
zy6hm6q45o970pkkl7
30 Apr 18
Other Events
7:15am